List of leading stocks in pharmaceutical retail sector
Fengyuan Pharmaceutical: The gross profit margin of the company is 34.66%, the net interest rate is 3.07%, the return on net assets is 7.57%, and the total operating income is 33.2 1 100 million, up by 2.57% year-on-year; Deducted non-net profit was 57.62 million, up 36. 15% year-on-year.
In addition to the nationwide drug distribution network, it also has a good drug logistics and retail business. Fengyuan Pharmacy is the largest pharmaceutical retail enterprise in Anhui Province, with 200 chain pharmacies, ranking among the top 50 pharmaceutical retail enterprises in China for many years.
Taiji Group: The company realized the total operating income of 1 12 1 billion, with a year-on-year increase of-3.74%; The net profit is-555 million, the gross profit margin is 40.4 1%, the net interest rate is 0.29%, and the return on net assets is 2.06%.
Pharmaceutical wholesale mainly sells medicines, medical devices and other medical supplies to retail and pharmaceutical circulation enterprises, and carries out professional logistics and distribution to the above units. The main profit source of drug wholesale is the difference between purchase and sale; Drug retailing mainly uses direct chain pharmacies and franchised chain pharmacies established by the company's wholesale and logistics network. The profit source of direct chain pharmacies is mainly through the difference between purchase and sale, and the income of joining chain pharmacies is mainly through unified distribution.
*ST Tangji: The gross profit margin of the company is 65,438+02.39%, the net interest rate is-2,665,438+0.12%, the return on net assets is -44.99%, and the total operating income is 894 million, with a year-on-year increase of-80.14%; Deducting non-net profit was-65.438+0.593 billion, a year-on-year increase of -654.38+0.677.92%.
Nanjing Medicine: The company achieved a total operating income of 39.82 billion, up 7.16% year-on-year; The net profit was 3.065438 billion +0 billion, up 6.33% year-on-year, the gross profit margin was 6.36%, the net interest rate was 1. 18%, and the return on net assets was 8.96%.
The company strengthened pharmaceutical services, actively built a multi-mode pharmaceutical retail business, and formed a "Nanjing Medical Health Management" retail brand with consumer health demand service and healthy interest management as the core. Combined with the development trend of "internet plus", we actively laid out and explored the practice in medical e-commerce, member management, chronic disease service, etc.
Shanghai Pharmaceutical: the net interest rate was 2.92%, the return on net assets was 10.34%, and the total operating income was191900 million, up by 2.86% year-on-year; Deducting non-net profit was 382 1 billion, up 10.4438+0% year on year.
The company is mainly engaged in drug manufacturing, drug circulation and drug retail.
Ma Yinglong: The gross profit margin of the company is 40.45%, the net interest rate is 15.43%, the return on net assets is 15.5 1%, and the total operating income is 2.792 billion, up 3.19% year-on-year; Deducted non-net profit was 327 million, up 65,438+0.99% year-on-year.
The company mainly focuses on the medical and health industry, and its business mainly includes pharmaceutical manufacturing, pharmaceutical retail and wholesale, and medical services. According to the Guidelines for Industry Classification of Listed Companies (revised 20 12) issued by China Securities Regulatory Commission, the company's industry is pharmaceutical manufacturing (C27).
Christie's Hall: The annual report shows that the gross profit margin of the company is 9. 18%, the net interest rate is 2.54%, the return on net assets is 9.0 1%, and the total operating income is 23.26 billion, up 4.82% year-on-year; Deducting non-net profit was 3,654,380,200 yuan, a year-on-year increase of-65,438+05.53%.